Search

TRENDS IN TONSIL CANCER INCIDENCE RATES IN THE US: 2000-2014

Pharynx / Larynx Cancer

Elizabeth Handorf, Miriam Lango, MD

Fox Chase Cancer Center

USE OF TRANSCERVICAL ULTRASOUND FOR IDENTIFICATION OF PRIMARY SITE IN PATIENTS WITH OROPHARYNGEAL CANCER

Pharynx / Larynx Cancer

C. Burton Wood, MD¹, Sarah L Rohde, MD¹, Robert Sinard, MD¹, Kyle Mannion, MD¹, Alexander Langerman, MD, SM¹, Young J Kim, MD, PhD¹, Joseph Aulino, MD, PhD¹, Derek K Smith, DDS, PhD¹, Arthur Fleischer, MD¹, Carole Fakhry, MD, MPH², James L Netterville, MD¹, Krystle L Kuhs, PhD, MPH¹

¹Vanderbilt University Medical Center, ²Johns Hopkins University

STAGING HPV-RELATED OROPHARYNGEAL CANCER: VALIDATION OF AJCC 8 IN A SURGICAL COHORT

Pharynx / Larynx Cancer

Mathew Geltzeiler, MD¹, William G Albergotti², John Gleysteen, MD¹, Marnie Bertolet², Michael Persky, MD², Neil D Gross, MD³, Ryan Li, MD¹, Peter Andersen, MD¹, Seungwon Kim, MD², Robert L Ferris², Umamaheswar Duvvuri², Daniel Clayburgh, MD¹

¹Oregon Health & Science University, ²University of Pittsburgh Medical Center, ³MD Anderson Cancer Center

TOWARDS A TUMOR-SPECIFIC DE-INTENSIFICATION STRATEGY IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS: USING TUMOR IMMUNOPHENOTYPES TO PREDICT PATIENT OUTCOMES

Pharynx / Larynx Cancer

Wesley H Stepp, PhD¹, Douglas Farquhar, MD¹, Angela Mazul, PhD¹, Jose Zevallos, MD²

¹University of North Carolina at Chapel Hill, ²Washington University in St. Louis

ABNORMAL MICROVASCULATURE IN LARYNGECTOMY MUCOSAL MARGINS IDENTIFIED ON FROZEN SECTION IS ASSOCIATED WITH INCREASED RISK OF FISTULA

Pharynx / Larynx Cancer

Marianne Abouyared, MD, Darcy Kerr, MD, Brandon Burroway, Zoukaa Sargi, MD, MPH, Jason Leibowitz, MD

University of Miami Miller School of Medicine

OCCULT CONTRALATERAL NODAL DISEASE IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA PATIENTS UNDERGOING PRIMARY TORS WITH BILATERAL NECK DISSECTION

Pharynx / Larynx Cancer

Caitlin McMullen, MD¹, Jonathan Garneau, MD², Emilie Weimar, MD³, Sana Ali, MD⁴, Joaquim Farinhas, MD, MBA⁵, Eugene Yu, MD, FRCPC³, Peter Som, MD², Cathy Sarta, RN⁴, David Goldstein, MD, MSc, FRCSC³, Susie Su, MSc³, Wei Xu, PhD³, Richard V Smith, MD⁴, Brett Miles, MD, DDS², John de Almeida, MD, MSc, FRCSC³

¹Moffitt Cancer Center, ²Mount Sinai Hospital, ³Princess Margaret Cancer Center, ⁴Montefiore Medical Center, ⁵Florida Hospital - Tampa

THE ROLE OF INTRAVENOUS ACETAMINOPHEN IN POST-OPERATIVE PAIN CONTROL IN HEAD AND NECK CANCER PATIENTS

Pharynx / Larynx Cancer

Erin J Smith, MD, MS¹, Jessica Lange, MD², Cindy Moore, MD¹, Lana Jackson, MD¹, Isaam Eid, MD³, Jesus Monico, MPH, MS¹

¹University of Mississippi Medical Center, ²Ear Nose and Throat Specialists, Lexington, Kentucky, ³University of Kansas Medical Center

EFFECT OF TREATMENT MODALITY ON CHRONIC OPIOID USE IN PATIENTS WITH T1/T2 OROPHARYNGEAL CANCER

Pharynx / Larynx Cancer

Craig A Bollig, MD, Jeffrey B Jorgensen, MD

University of Missouri Dept. of Otolaryngology Head and Neck Surgery

OCCULT NODAL DISEASE AND OCCULT EXTRANODAL EXTENSION IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA PATIENTS UNDERGOING PRIMARY TORS WITH NECK DISSECTION

Pharynx / Larynx Cancer

Caitlin McMullen, MD¹, Garneau Jonathan, MD², Emilie Weimar, MD³, Ali Sana, MD⁴, Joaquim Farinhas, MD, MBA⁵, Eugene Yu³, Peter Som, MD², Cathy Sarta⁴, David Goldstein, MD, MSc, FRCSC³, Su Susie, MSc³, Wei Xu, PhD³, Richard Smith, MD⁴, Brett Miles, MD, DDS², John de Almeida, MD, MSc, FRCSC³

¹Moffitt Cancer Center, ²Mount Sinai Hospital, ³Princess Margaret Cancer Center, ⁴Montefiore Medical Center, ⁵Florida Hospital - Tampa

DELAYS DURING TREATMENT FOR LARYNGEAL SQUAMOUS CELL CARCINOMA: AN ANALYSIS OF THE NATIONAL CANCER DATABASE

Pharynx / Larynx Cancer

Elliot Morse, BS, Benjamin Judson, MD, Saral Mehra, MD, MBA

Department of Surgery, Division of Otolaryngology, Yale University School of Medicine, New Haven, CT, 06520, USA